Jurors didn’t buy the Novartis lawyer’s argument that the women were a bunch of hysterics.
Trying to discredit your opponents is a common and acceptable litigation tactic—within bounds. But did Novartis Pharmaceutical Corporation go too far? In a recent gender discrimination class action, the drugmaker was accused of insensitivity and hostility by its female employees. It responded by labeling them with demeaning and insulting stereotypes.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
